Terms of use

Company OSE Immunotherapeutics

Société Anonyme (Stock Corporation) with a share capital of 2.874.994 €
Registered in the Nantes Trade and Company Register under number 479 457 715
N° VAT : FR 24 479 457 715

Head Office:
22, boulevard Benoni Goullin
44200 Nantes
Phone number: +33 (0)2 28 29 41 67

Hosting site : OVH

Webdesign : Limbus Studio

Disclaimer

Information supplied on Ose-immuno.com is for information purposes only and may expressly or implicitly contain certain forward-looking statements concerning OSE Immunotherapeutics and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of OSE Immunotherapeutics to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. OSE Immunotherapeutics does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise. For a discussion of risks and uncertainties which could cause actual results, financial condition, performance or achievements of OSE Immunotherapeutics to differ from those contained in the forward-looking statements, please refer to the OSE Immunotherapeutics Reference Document filed with the AMF on 8 June 2016 under the number R.16-052, the consolidated financial statements and the management report for the fiscal year 2015, as well as the Merger Document registered with the AMF on 26 April 2016 under number E.16-026, all available on the OSE Immunotherapeutics website.